For example, we find that both BRD9 and BRG1 occupancies are reduced at AML-specific enhancers of Myc, accompanied by a strong reduction in chromatin accessibility and enhancer RNAs (eRNA) transcription at the individual enhancer elements. The gene discussed is BRD9; the disease is acute myeloid leukemia.